{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:23:51Z","timestamp":1770042231334,"version":"3.49.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>The use of p57 immunohistochemistry (IHC) can distinguish complete mole (CM) from partial mole (PM) and nonmolar abortus (NMA). Molecular genotyping (MG) is the gold standard method for the definitive diagnosis of PM and NMA. However, MG is expensive and not always available. Some data suggest Ki-67 IHC may be helpful in distinguishing NMAs from PMs and could be a substitute for MG. In this study, we examined the utility of p57 and Ki-67 IHC stains in the diagnosis of placental molar disease. The study cohort consisted of 60 cases of products of conception (20 CMs, 20 PMs, and 20 NMAs). All CM cases showed absent (&lt;10%) p57 IHC in chorionic villi. All PM and NMA cases had been subjected to MG and showed diandric triploid or biparental inheritance, respectively. Ki-67 and p57 IHC staining was done on formalin-fixed paraffin-embedded sections from all 60 cases. Both IHC stains were interpreted blinded to the diagnosis. On rereview, we recorded the percentage of cells with nuclear p57 staining in villous cytotrophoblast and stromal cells. Ki-67 proliferative index (%) was determined by manual count of at least 500 villous cytotrophoblastic cells in areas with highest Ki-67 reactivity. Any intensity of nuclear staining was considered positive. The utility of p57 IHC is mainly to exclude or confirm CM. Although there is a significantly higher Ki-67 expression in CMs in comparison to PMs and NMAs, this did not add diagnostic utility. PMs tend to have higher Ki-67 expression than NMAs; however, the difference is not statistically significant. Our data suggest that the use of p57 and Ki-67 IHC cannot reliably distinguish PM from NMAs.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000558","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:05:59Z","timestamp":1541117159000},"page":"1-7","source":"Crossref","is-referenced-by-count":7,"title":["Does Ki-67 Have a Role in the Diagnosis of Placental Molar Disease?"],"prefix":"10.1097","volume":"39","author":[{"given":"Rofieda","family":"Alwaqfi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence J.","family":"Colgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0046-8177(93)90061-K","article-title":"Diagnostic considerations in molar gestations","volume":"24","author":"Conran","year":"1993","journal-title":"Hum Pathol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/01.pas.0000157996.23059.c1","article-title":"Interobservor and intraobservor variability in the diagnosis of hydatidiform mole","volume":"29","author":"Funkunaga","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/PAS.0b013e318191f309","article-title":"Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach","volume":"33","author":"McConnell","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/00000478-200110000-00001","article-title":"Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57 KIP2","volume":"25","author":"Castrillon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/PAS.0b013e31823b13fe","article-title":"Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis","volume":"36","author":"Vang","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/modpathol.2013.143","article-title":"Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping","volume":"27","author":"Banet","year":"2014","journal-title":"Mod Pathol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.humpath.2007.05.010","article-title":"p57kip2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic\/chimeric conceptions","volume":"39","author":"Hoffner","year":"2008","journal-title":"Hum Pathol"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1084-8592(99)80045-9","article-title":"Molecular genetic testing from paraffin-embedded tissue distinguishes nonmolar hydropic abortion from hydatidiform mole","volume":"4","author":"Bell","year":"1999","journal-title":"Mol Diagn"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/PAS.0b013e3181520034","article-title":"Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis","volume":"32","author":"Bifulco","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2353\/jmoldx.2009.090039","article-title":"Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay","volume":"11","author":"Murphy","year":"2009","journal-title":"J Mol Diagn"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1586\/erm.10.93","article-title":"Molecular diagnosis of gestational trophoblastic disease","volume":"10","author":"Hui","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004347-199604000-00011","article-title":"p53, PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study","volume":"15","author":"Schammel","year":"1996","journal-title":"Int J Gynecol Pathol"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"e0158891","DOI":"10.1371\/journal.pone.0158891","article-title":"Clinicopathological and prognostic value of Ki-67 expression in bladder cancer: a systematic review and meta-analysis","volume":"11","author":"Tian","year":"2016","journal-title":"PLoS One"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02893360","article-title":"The clinical value of Ki-67\/MIB-1 labeling index in human astrocytomas","volume":"12","author":"Johannessen","year":"2006","journal-title":"Pathol Oncol Res"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.breast.2008.02.002","article-title":"Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients","volume":"17","author":"Stuart-Harris","year":"2008","journal-title":"Breast"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1200\/JCO.2008.17.0829","article-title":"Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole","volume":"26","author":"Viale","year":"2008","journal-title":"J Clin Oncol"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"44281","DOI":"10.1038\/srep44281","article-title":"Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis","volume":"7","author":"Xie","year":"2017","journal-title":"Sci Rep"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/1097-0142(20001001)89:7<1457::AID-CNCR7>3.0.CO;2-L","article-title":"Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma","volume":"89","author":"Shiba","year":"2000","journal-title":"Cancer"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"547","DOI":"10.21037\/tlcr.2016.10.13","article-title":"Ki-67 expression in pulmonary tumors","volume":"5","author":"Chirieac","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.3892\/or.2014.3079","article-title":"Ki-67 as an independent prognostic factor in an unselected cohort of patients with ovarian cancer: results of an explorative, retrospective study","volume":"31","author":"Battista","year":"2014","journal-title":"Oncol Rep"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/pcan.2016.12","article-title":"Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies","volume":"19","author":"Tretiakova","year":"2016","journal-title":"Prostate Cancer and Prostatic Disease"},{"key":"R25-20230824","first-page":"EC14","article-title":"Study of immunohistochemical markers (CK-19, CD-56, Ki-67, p53) in differentiating benign and malignant solitary thyroid nodules with special reference to papillary thyroid carcinomas","volume":"10","author":"Dwivedi","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/PAS.0000000000000478","article-title":"MIB-1 Index as a surrogate for Mitosis-Karyorrhexis Index in neuroblastoma","volume":"39","author":"Atikankul","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajh.21406","article-title":"Role and prognostic significance of the Ki-67 index in non-Hodgkin\u2019s lymphoma","volume":"84","author":"Broyde","year":"2009","journal-title":"Am J Hematol"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/modpathol.3880432","article-title":"Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27kip1, and Ki-67 in normal placenta and gestational trophoblastic disease","volume":"14","author":"Olvera","year":"2001","journal-title":"Mod Pathol"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/PGP.0000000000000165","article-title":"Placental molar disease: what are the benefits and barriers to the adoption of a comprehensive diagnostic service?","volume":"34","author":"Kolomietz","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/PGP.0b013e3181f4de77","article-title":"Hydatidiform moles: ancillary techniques to refine diagnosis","volume":"30","author":"Ronnett","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1067\/mob.2001.111243","article-title":"Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease","volume":"184","author":"Kale","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R35-20230824","first-page":"375","article-title":"P63 and Ki-67 expression in trophoblastic disease and spontaneous abortion","volume":"14","author":"Erfanian","year":"2009","journal-title":"J Res Med Sci"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5812\/ircmj.5348","article-title":"Ki-67 expression in hydatidiform moles and hydropic abortions","volume":"15","author":"Khooei","year":"2013","journal-title":"Iran Red Crescent Med J"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ajcp\/aqy012","article-title":"Diagnostic utility of Twist1, Ki-67, and E-Cadherin in diagnosing molar gestations and hydropic abortions","volume":"149","author":"Moussa","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"R38-20230824","first-page":"151","article-title":"The importance of immunohistochemistry in the differential diagnosis of molar disease","volume":"108","author":"Luchini","year":"2016","journal-title":"Pathologica"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/PAI.0000000000000175","article-title":"CD71 in gestational pathology: a versatile immunohistochemical marker with new possible applications","volume":"24","author":"Luchini","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R40-20230824","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5858\/arpa.2012-0047-OA","article-title":"Diagnostic utility of microsatellite genotyping for molar pregnancy testing","volume":"137","author":"Furtado","year":"2013","journal-title":"Arch Pathol Lab Med"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:43:09Z","timestamp":1692841389000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000558","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}